An Approach for Cure: PEI-Chemotherapy and Regional Deep Hyperthermia in Children and Adolescents with Unresectable Malignant Tumors

Klinische Padiatrie

Volumn 215, Issue 6, 2003, Pages 303-309

  Wessalowski, R ^a,d   Schneider, D T ^a   Mils, O ^a   Hannen, M ^a   Calaminus, C ^a   Engelbrecht, V ^b   Pape, H ^c   Willers, R ^d   Engert, J ^e   Harms, D ^f   Gobel U ^a  

^a Clinik Pediat Oncol Hematol I   (Germany)

^b Institute of Diagnostic Radiology   (Germany)

^c Department of Radiation Oncology ^*

^d HEINRICH HEINE UNIVERSITY   (Germany)

^e RUHR UNIVERSITY BOCHUM   (Germany)

^f UNIVERSITY OF KIEL   (Germany)

Author keywords

Germ cell tumor; Hyperthermia; Sarcoma; Thermochemotherapy

Indexed keywords

CARBOPLATIN; CISPLATIN; COTRIMOXAZOLE; ETOPOSIDE; IFOSFAMIDE; NYSTATIN;

ADOLESCENT; ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER SURGERY; CHILD; CLINICAL ARTICLE; COHORT ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISEASE COURSE; FEMALE; FOLLOW UP; GERM CELL TUMOR; HIGH RISK PATIENT; HIGH RISK POPULATION; HUMAN; HYPERTHERMIA; MALE; MALIGNANT NEOPLASTIC DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIMARY MEDICAL CARE; RELAPSE; SURVIVAL RATE;

ABDOMINAL NEOPLASMS; ADOLESCENT; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BONE NEOPLASMS; CHEMOTHERAPY, ADJUVANT; CHI-SQUARE DISTRIBUTION; CHILD; CHILD, PRESCHOOL; CHONDROSARCOMA; CISPLATIN; COMBINED MODALITY THERAPY; DATA INTERPRETATION, STATISTICAL; ETOPOSIDE; FEMALE; FOLLOW-UP STUDIES; GERMINOMA; HEAD AND NECK NEOPLASMS; HUMANS; HYPERTHERMIA, INDUCED; IFOSFAMIDE; INFANT; KARNOFSKY PERFORMANCE STATUS; LUMBAR VERTEBRAE; MALE; NEOADJUVANT THERAPY; NEOPLASM RECURRENCE, LOCAL; PELVIC NEOPLASMS; SARCOMA; SOFT TISSUE NEOPLASMS; SPINAL NEOPLASMS; TIME FACTORS; TREATMENT OUTCOME;

EID: 9144271654     PISSN: 03008630     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2003-45500     Document Type: Article

References (25)

1. Debes A, Rommel F, Breise M, Willers R, Göbel U, Wessalowski R. In vitro test-system for chemo- and thermosensitivity: an analysis of survival fractions and cell-cycle distributions in human Ewing's sarcomas as a model for tumors in pédiatric oncology. Klin Pädiatr 2002; 214:223-229
2. Hashimoto T, Shibata MA, Ito Y, Nakao KI, Sasaki S, Otsuki Y. Elevated levels of intracellular Ca(2+) and apoptosis inhuman lung cancer cells given heat-shock. Int J Hyperthermia 2003; 19: 178-192
3. Hildebrandt B, Wust P, Ahlers O, Dieing A, Sreenivasa G, Kerner T, Felix R, Riess H. The cellular and molecular basis of hyperthermia. Crit Rev Oncol Hematol 2002; 43: 33-56
4. Issels RD, Prenninger SW, Nägele A, Boehm E, Sauer H, Jauch KW, Denecke H, Berger H, Peter K, Wilmanns W. Ifosfamide plus etoposide combined with regional hyperthermia in patients with locally advanced sarcomas: a phase II study. J Clin Oncol 1990; 8: 1818-1829
5. Klingebiel T, Pertl U, Hess CF, Jürgens H, Koscielniak E, Pötter R, van Heek-Romanowski R, Rossi R, Schött C, Spaar HJ, Willnow U, Treuner J. Treatment of children with relapsed soft tissue sarcoma: report of the German CESS/CWS REZ 91 trial. Med Pediatr Oncol 1998; 30: 269-275
6. Längler A, Christaras A, Abshagen K, Krauth K, Hero B, Berthold F. Topotecan in the treatment of refractory neuroblastoma and other malignant tumors in childhood - a phase-II-study. Klin Pädiatr 2002; 214: 153-156
7. Otte J. Hyperthermia in cancer therapy. EurJ Pediatr 1988; 147: 560-569
8. Overgaard J, Gonzalez GD, Hulshof MC, Arcangeli G, Dahl O, Mella O, Bentzen SM. Randomised trial of hyperthermia as adjuvant to radiotherapy for recurrent or metastatic malignant melanoma. Lancet 1995; 345: 540-543
9. Paulussen M, Ahrens S, Craft AW, Dunst J, Fröhlich B, Jabar S, Rube C, Winkelmann W, Wissing S, Zoubek A, Jürgens H. Ewing's tumors with primary lung métastases: survival analysis of 114 (European Intergroup) Cooperative Ewing's Sarcoma Studies patients. J Clin Oncol 1998; 16: 3044-3052
10. Raaphorst GP, Ng CE, Shahine B. Comparison of radiosensitization by 41 degrees C hyperthermia during low dose rate irradiation and during pulsed simulated low dose rate irradiation in human glioma cells. Int J Radiat Oncol Biol Phys 1999; 44: 185-188
11. Romanowski R, Schott C, Issels R, Klingebiel T, Treuner J, Jürgens H, Göbel U, Goldschmitt-Wuttge B, Feldmann H, Haas R. Regional hyperthermia with systemic chemotherapy in children and adolescents: feasibility and clinical follow-up of 34 intensively pretreated patients with prognostically unfavorable tumor diseases. Klin Pädiatr 1993; 205: 249-256
12. Saylors RL, III, Stine KC, Sullivan J, Kepner JL, Wall DA, Bernstein ML, Harris MB, Hayashi R, Vietti TJ. Cyclophosphamide plus topotecan in children with recurrent or refractory solid tumors: a Pediatric Oncology Group phase II study. J Clin Oncol 2001; 19: 3463-3469
13. Schneider DT, Wessalowski R, Calaminus G, Pape H, Bamberg M, Engert J, Waag K, Gadner H, Göbel U. Treatment of recurrent malignant sacrococcygeal germ cell tumors: analysis of 22 patients registered in the German protocols MAKEI 83/86,89, and 96. J Clin Oncol 2001; 19: 1951-1960
14. Shankar AG, Ashley S, Craft AW, Pinkerton CR. Outcome after relapse in an unselected cohort of children and adolescents with Ewing sarcoma. Med Pediatr Oncol 2003; 40: 141-147
15. Urano M, Kuroda M, Nishimura Y. For the clinical application of TCH given at mild temperatures [In Process Citation]. Int J Hyperthermia 1999; 15: 79-107
16. van der Zee J, Gonzalez GD, van Rhoon GC, van Dijk JD, van Putten WL, Hart AA. Comparison of radiotherapy alone with radiotherapy plus hyperthermia in locally advanced pelvic tumours: a prospective, randomized, multicentre trial. Lancet 2000; 355: 1119-1125
17. Vaupel P, Kelleher DK, Thews O. Modulation of tumor oxygénation. Int J Radiat Oncol Biol Phys 1998; 42: 843-848
18. Vernon CC, Hand JW, Field SB, Machin D, Whaley JB, van der Zee J, van Putten WL, van Rhoon GC, van Dijk JD, Gonzalez GD, Liu FF, Goodman P, Sherar M. Radiotherapy with or without hyperthermia in the treatment of superficial localized breast cancer: results from five randomized controlled trials. International Collaborative Hyperthermia Group. Int J Radiat Oncol Biol Phys 1996; 35: 731-744
19. Wendtner CM, Abdel-Rahman S, Krych M, Baumert J, Lindner LH, Baur A, Hiddemann W, Issels RD. Response to neoadjuvant chemotherapy combined with regional hyperthermia predicts long-term survival for adult patients with retroperitoneal and visceral high-risk soft tissue sarcomas. J Clin Oncol 2002; 20 (14): 3156-3164
20. Wessalowski R, Blohm M, Calaminus G, Engert J, Harms D, Krause I, Kruck H, Grüttner HP, Pape H, Göbel U. Treatment results in children and adolescents with loco-regional recurrences of abdominal germ cell tumors (GCTs): a pilot-study with PEI chemotherapy and regional deep hyperthermia (RHT) in comparison to a matched cohort. Klin Pädiatr 1997; 209: 250-256
21. Wessalowski R, Kruck H, Pape H, Kahn T, Willers R, Göbel U. Hyperthermia for the treatment of patients with malignant germ cell tumors: a phase I/II study in ten children and adolescents with recurrent or refractory tumors. Cancer 1998; 82: 793-800
22. Wessalowski R, van Heek-Romanowski R, Issels RD, Jürgens H, Göbel U. Estimated number of children eliagible for hyperthermia based on population- and treatment-related criteria. Int J Hyperthermia 1999; 15: 455-466
23. Wessalowski R. Regionale Tiefenhyperthermie und Chemotherapie bei Tumoren von Kindern und Erwachsenen. Experimentelle und klinische Untersuchungen. Aachen: Shaker Verlag, 2002: 1-205
24. Willnow U, Lindner H, Brock D, Wild L, Diestelhorst C, Greiner C, Eichstadt H. Treatment of otherwise incurable tumor diseases in childhood using whole-body hyperthermia and chemotherapy. Dtsch Med Wochenschr 1989; 114: 208-213
25. Wust P, Hildebrandt B, Sreenivasa G, Rau B, Gellermann J, Riess H, Felix R, Schlag PM. Hyperthermia in combined treatment of cancer. Lancet Oncol 2002; 3: 487-497